Reimbursed with a limitationOriginator productATC B02BX08

Doptelet

Doptelet is an originator product from Swedish Orphan Biovitrum AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 691.10 to CHF 2'040.50 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Swedish Orphan Biovitrum AG
ATC code
B02BX08
IT group
06.99 Varia
Active substances
Avatrombopagum
Preparation type
Originator product
On the SL since
01/01/2022
Last price change
01/12/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Doptelet Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 20 mgBlist 10 StkCHF 620.37CHF 691.1001/01/2022A7680678930019
Filmtabl 20 mgBlist 15 StkCHF 930.56CHF 1'028.4501/01/2022A7680678930026
Filmtabl 20 mgBlist 30 StkCHF 1'861.11CHF 2'040.5001/01/2022A7680678930033

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/01/2022

Zur Behandlung einer schweren Thrombozytopenie bei erwachsenen Patienten mit chronischer Lebererkrankung (CLD), bei denen ein invasiver Eingriff geplant ist und die zu Beginn der Behandlung eine Thrombozytenzahl von mindestens 20 * 109/L aufweisen.
Zur Behandlung von erwachsenen Patienten mit chronischer Immunthrombozytopenie (immunthrombozytopenischer Purpura, ITP) definiert als eine mindestens 12 Monate ab Diagnose dauernde ITP. Die Patienten müssen auf mindestens eine vorherige Behandlung (zum Beispiel Kortikosteroide, Azathioprin oder Immunglobuline) unzureichend angesprochen haben. DOPTELET darf nicht in Kombination mit REVOLADE oder NPLATE verabreicht werden.

FAQ

Is Doptelet covered by Swiss health insurance?

Yes, but only under conditions. Doptelet is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Doptelet cost in Switzerland?

The public price is the maximum price set by the FOPH and for Doptelet ranges from CHF 691.10 to CHF 2'040.50 per pack. The ex-factory price ranges from CHF 620.37 to CHF 1'861.11. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com